BRKR · XBRL financial data

Bruker financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (BRKR's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	1,988	2,418	2,531	2,965	3,366	3,437
Cost of revenue	1,048	1,208	1,225	1,451	1,717	1,859
Gross profit	940	1,210	1,306	1,513	1,650	1,578
Research and development	198	221	236	295	377	395
Selling, general and administrative	469	561	607	729	894	947
Total operating expenses	692	796	873	1,076	1,396	1,510
Other operating income (expense)	—	0	1	4	0	(1)
Operating income (loss)	248	413	433	437	253	68
Interest income	3	1	3	8	9	15
Interest expense	14	14	16	16	48	60
Other income (expense)	—	(20)	(19)	(37)	(38)	(46)
Income tax expense (benefit)	64	113	116	118	91	29
Net income (loss)	158	277	297	427	113	(9)
Earnings per share, basic USD per share	1.03	1.83	2.00	2.92	0.76	(0.15)
Earnings per share, diluted USD per share	1.02	1.81	1.99	2.90	0.76	(0.15)
Weighted average shares, basic millions of shares	153	0	0	0	0	152
Weighted average shares, diluted millions of shares	155	0	0	0	0	152

Fiscal years (BRKR's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	682	1,068	646	488	183	299
Short-term investments	50	100	0	—	—	—
Accounts receivable	335	417	473	492	566	545
Inventory	692	710	800	968	1,068	1,095
Total current assets	1,925	2,472	2,113	2,164	2,053	2,213
Property and equipment, net	396	406	487	600	669	745
Right-of-use asset	67	60	51	92	146	166
Goodwill	320	340	458	583	1,507	1,548
Total assets	3,049	3,650	3,612	4,250	5,807	6,241
Accounts payable	135	147	178	203	234	216
Total current liabilities	792	939	914	1,202	1,281	1,279
Long-term debt	842	1,222	1,201	1,160	2,062	1,853
Lease liability, non-current	47	42	35	75	119	139
Total liabilities	—	—	2,480	2,837	3,992	3,731
Retained earnings	1,407	1,660	1,926	2,324	2,407	2,362
Total stockholders' equity	961	1,071	1,114	1,377	1,781	2,457
Total liabilities and equity	3,049	3,650	3,612	4,250	5,807	6,241
Common shares outstanding (cover page) millions of shares	152	151	147	138	152	152

Fiscal years (BRKR's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	158	277	297	427	113	(9)
Stock-based compensation	16	17	28	24	25	20
Depreciation and amortization	80	89	89	115	184	220
Net cash from operating activities	332	282	274	350	251	134
Purchases of property and equipment	97	92	129	107	115	91
Net cash from investing activities	(193)	(192)	(252)	(326)	(1,757)	(197)
Proceeds from issuing common stock	3	7	3	10	6	8
Share repurchases	123	153	263	152	0	10
Dividends paid	25	24	30	29	30	23
Proceeds from long-term debt	0	493	0	2	974	4
Repayments of long-term debt	—	1	111	24	135	467
Net cash from financing activities	(162)	319	(415)	(193)	1,230	135
Net change in cash	4	386	(423)	(157)	(305)	116

SIC 3826 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3826 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
Bruker	120	874	118*	not reported	Q3 FY26 10-QSep 30, 2026
Sensata Technologies Holding	553	1,004	225*	145.6M	Q3 FY26 10-QSep 30, 2026
Mirion Technologies	409	278	59*	not reported	Q3 FY26 10-QSep 30, 2026
Cognex	695	313	106*	168.4M	Q3 FY26 10-QOct 4, 2026
Vontier	258	737	143*	132.8M	Q3 FY26 10-QOct 2, 2026
Bio-Rad Laboratories	465	656	96*	not reported	Q3 FY26 10-QSep 30, 2026
Ralliant	366	620	111*	110.9M	Q3 FY26 10-QOct 2, 2026
Itron	840	599	102*	43.9M	Q3 FY26 10-QSep 30, 2026
MKS	511	1,413	292*	67.6M	Q3 FY26 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched Nov 6, 2026, 9:19 AM ET. The filing on SEC.gov is the record.